Current Opinion in Oncology

Article	Citations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	59
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	41
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	38
Role of PSMA PET/CT in imaging and management of prostate cancer	32
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	30
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	28
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	26
Treatments and challenges in advanced prostate cancer	23
Harnessing dendritic cells for innovative therapeutic cancer vaccines	23
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	21
Editorial introductions	20
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	19
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	18
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	18
Psycho-oncology interventions focusing on fatigue and sleep disturbances	17
Editorial introductions	16
Importance of guidelines and networking for the management of rare gynecological cancers	16
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	16
Editorial introductions	15
Biomarkers and immunotherapy: where are we?	15
Safety of assisted reproductive techniques in gynecological cancer patients	15
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	14
New hopes in relapsed refractory primary central nervous system lymphoma	13
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	13
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	12

Neoadjuvant and adjuvant approaches in gastroesophageal cancers	12
How to prevent human papillomavirus-related oropharyngeal cancer?	12
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	12
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	11
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	11
Circulating tumor DNA in breast cancer: a biomarker for patient selection	11
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	11
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights	11
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	11
Recent advances in precision medicine for acute myeloid leukemia	11
Liquid biopsy in brain tumors: moving on, slowly	10
Immunomodulation for hepatocellular carcinoma therapy: current challenges	10
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	10
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	10
Lung cancer screening in never smokers	10
Editorial introductions	10
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	10
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	9
Pathology and new insights in central nervous system lymphomas	9
Editorial: Lung cancer: continuous progress in diagnosis and treatment	9
Machine learning applications and challenges in graft-versus-host disease: a scoping review	9
New developments in rare vulvar and vaginal cancers	9
Editorial introductions	9
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	9
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	9
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	9
Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics	8
Desmoid tumors: who, when and how to treat?	8
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	8
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	8
Editorial introductions	8
Primary vitreoretinal lymphoma: short review of the literature, results of a European survey and French guidelines of the LOC network for diagnosis, treatment and follow-up	8
The role of genetic testing in prostate cancer screening, diagnosis, and treatment	8
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	7
The changing landscape for patients with relapsed/refractory acute myeloid leukaemia	7
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	7
Editorial introductions	7
Mind the target: programmed death ligand 1 in oesophagogastric cancers	7
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	7
How to support parenting in patients with cancer and co-parents? From research to practice	7
Preclinical glioma models in neuro-oncology: enhancing translational research	7
Potential application of artificial intelligence in cancer therapy	7
Editorial introductions	7
The 5T's of health disparities in multiple myeloma in Latin America	7
A new comprehensive and stratified concept for supportive care in cancer patients	7
Advantages of robotic surgery in obese patients with endometrial cancer	7
Editorial introductions	7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	7
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	7
Question prompt lists to improve communication between cancer patients and healthcare professionals	6

Editorial introductions	6
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	6
Adjuvant and neoadjuvant approaches in pancreatic cancer	6
Targeting cancer stem cell pathways for lung cancer therapy	6
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
Immunotherapies in non-metastatic gastrointestinal cancers	6
Editorial introductions	6
Targeting SUMOylation in cancer	6
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	6
Treatment of radiation-associated angiosarcoma	6
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	6
Breast surgery after neoadjuvant therapy	6
Pathologic diagnosis of lung cancer – recent developments	6
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	6
Polyamine metabolism in prostate cancer	5
Cellular therapies in sarcoma and other solid tumors	5
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	5
Thymic malignancies: role of immunotherapy and novel approaches	5
Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?	5
Update on bi-specific monoclonal antibodies for blood cancers	5
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	5
Achievements of international rare cancers networks and consortia in the neuro-oncology field	5
HIV-related lymphomas	5
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	5
Recent advances in immunotherapy for small cell lung cancer	5
Immunotherapy of sarcomas with modified T cells	5
Preoperative immunotherapy for head and neck cancers: state of art	5
How to monitor the side effects of treatments in cancer patients	5
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	5
Clinical management of brain tumors in pregnancy	5
How to treat localized Hodgkin lymphoma?	5
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas	5
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	5
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	5
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	4
Recent advances in allogeneic transplantation for acute myeloid leukemia	4
Optimizing the prescription doses and tolerability of systemic therapy in head and neck cancer patients	4
Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?	4
Ovarian stimulation and oocyte cryopreservation in females with cancer	4
Perioperative immunotherapy in nonsmall cell lung cancer	4
How to treat advanced Hodgkin lymphoma?	4
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice	4
Evolving systemic management of urothelial cancers	4
Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy	4
Advances in the treatment of light chain amyloidosis	4
Future of sentinel node biopsy in ovarian cancer	4
Vascular complications in patients with brain tumors	4
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients	4
Targeting exon 20 insertion mutations in lung cancer	4
Precision medicine in extended adjuvant endocrine therapy for breast cancer	4
Editorial: Psychological interventions in oncology: advances and challenges	4
New treatments for desmoid tumors	4
New strategies for the treatment of breast cancer with leptomeningeal metastasis	4
Postneoadjuvant treatment for triple-negative breast cancer	4
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	4
Editorial introductions	4
Update of antibody–drug conjugates for hematological malignancies	4
New trends in supportive care of head and neck cancers	4
Early Detection of Cancers in the Era of Precision Oncology	4
Molecular genotyping in medullary thyroid cancer	4
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	4
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	4
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma	4
Maintenance therapies in acute myeloid leukemia: the renaissance of an old therapeutic concept	3
Hairy cell leukemia: a brief update on current knowledge and treatment prospects	3
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Treatment of small cell lung cancer: recent advances	3
New horizons in early drugs development in solid cancers	3
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	3
Unveiling the role of cellular dormancy in cancer progression and recurrence	3
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019–2021	3
Immunotherapy in rare ovarian cancer	3
Editorial Introductions	3
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?	3
The role of next-generation sequencing in acute myeloid leukemia	3
Action against thoracic cancers: recent achievements and perspectives	3
CIC-DUX4 sarcomas	3

New targeted treatments for advanced sarcomas	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
Cancer-associated thrombosis: what is new?	3
Use of staging for sex cord stromal tumours	3
Perioperative immunotherapy for nonsmall cell lung cancer	3
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	3
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	3
Advance care planning in oncology: a scoping review and some recommendations	3
Editorial introductions	3
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	3
Challenges in the management of relapsed germ cell tumors	3
Advances in testing for human papillomavirus-mediated head and neck cancer	3
Highlights of recent research focused on the treatment of advanced prostate cancer	3
Editorial: Advanced care planning	3
First line treatments in primary central nervous system lymphomas in young patients	3
Emerging therapies in Ewing sarcoma	3
Artificial intelligence: opportunities in lung cancer	2
Active surveillance in favorable intermediate risk prostate cancer: outstanding questions and controversies	2
Primary central nervous system lymphoma (PCNSL) in older patients	2
Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA	2
Sarculator: how to improve further prognostication of all sarcomas	2
Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer	2
Editorial introductions	2
Biomarkers in advanced renal cell carcinoma: current practice and future directions	2
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma	2
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine	2
Novel immunotherapeutic drugs for the treatment of lung cancer	2
A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword?	2
Medical treatment of angiosarcomas	2
Interventions for children of parents with cancer: an overview	2
Postmastectomy radiotherapy: a review	2
Surrogate endpoints for HTA decisions of breast cancer drugs: utility and pitfalls	2
Immuno-oncology in the daily practice	2
The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma	2
Targeted radionuclide therapy: an emerging field in solid tumours	2
Immune checkpoint inhibitors in elderly patients with lung cancer: evidence from phase 3 trials	2
Management of epilepsy in brain tumor patients	2
New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions	2
Immunotherapy in first line treatment of adult acute lymphoblastic leukemia	2
Treatment of anaplastic gliomas: evidences and controversies	2
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps	2
Recent advances in primary resistance mechanisms against immune checkpoint inhibitors	2
Pediatric brain tumors as a developmental disease	2
Editorial: Advances in cancer detection and diagnosis: from liquid biopsies and molecular biomarkers to opportunistic intratumoral bacteria	2
Resistance mechanisms to osimertinib and emerging therapeutic strategies in nonsmall cell lung cancer	2
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy	2
Chemotherapy-induced nausea and vomiting: can we do better?	2
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?	2
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities	2
Implementation of sentinel node biopsy in high-risk endometrial cancer	2
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	2
Editorial: ’All you need is immunotherapy’: a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?	2
Treatment approaches for older Hodgkin lymphoma patients	2
Novel therapeutics in refractory germ cell tumors	2
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives	2
New targeted therapies in liposarcoma: state of art and future perspectives	2
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA	2
Nanoparticle therapy for head and neck cancers	2
The role of autologous stem-cell transplantation in multiple myeloma in 2021	2
Active surveillance and emerging medical treatment options for desmoid: when and for whom?	2
Editorial: Less is more in gynaecological oncology: paving the way for the future	2